Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors
Crossref DOI link: https://doi.org/10.1208/s12248-016-9884-3
Published Online: 2016-02-23
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buil-Bruna, Núria
Dehez, Marion
Manon, Amandine
Nguyen, Thi Xuan Quyen
Trocóniz, Iñaki F.
Text and Data Mining valid from 2016-02-23